ArticleJournal of medical ethics2020
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.
Article in Journal of medical ethics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Methodological and Ethical Implications of Using Remote Data Collection Tools to Measure Sexual and Reproductive Health and Gender-Based Violence Outcomes among Women and Girls in Humanitarian and Fragile Settings: A Mixed Methods Systematic Review of Peer-Reviewed Research.Trauma, violence & abuse · 2023Pooled it
- Equitable data sharing in epidemics and pandemics.BMC medical ethics · 2021Pooled it
- Community perspectives on COVID-19 vaccine allocation ethical principles in Uganda: a cross-sectional study.Frontiers in public health · 2026Article
- On value compatibility: reflections on the ethical framework for pandemic healthcare distribution.Medicine, health care, and philosophy · 2025Article
- Vaccine equity implementation: exploring factors influencing COVID-19 vaccine delivery in the Philippines from an equity lens.BMC public health · 2024Article
- Medical Resource Management in Emergency Hierarchical Diagnosis and Treatment Systems: A Research Framework.Healthcare (Basel, Switzerland) · 2024Article
- Rationing, Responsibility, and Vaccination during COVID-19: A Conceptual Map.The American journal of bioethics : AJOB · 2024Article
- Balancing the benefits of vaccination: AnPNAS nexus · 2024Article
- Evaluation of vaccine rollout strategies for emerging infectious diseases: A model-based approach including protection attitudes.Infectious Disease Modelling · 2023Article
- An optimal control model for Covid-19 spread with impacts of vaccination and facemask.Heliyon · 2023Article
- Inequality in COVID-19 vaccination in Africa.Journal of public health in Africa · 2023Article
- Ethical considerations of the vaccine development process and vaccination: a scoping review.BMC health services research · 2023Article
- A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.Socio-economic planning sciences · 2023Article
- Vaccine equity in COVID-19: a meta-narrative review.BMJ global health · 2022Review
- Ethical Approaches to Vaccine Allocation and Administration in Carceral Settings, With a Focus on Youth.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2022Article
- Which countries need COVID-19 vaccines the most? Development of a prioritisation tool.BMC public health · 2022Article
- Health, Economic and Social Development Challenges of the COVID-19 Pandemic: Strategies for Multiple and Interconnected Issues.Healthcare (Basel, Switzerland) · 2022Review
- A public health framework for the equitable global allocation of vaccines: COVID-NEEDS.Journal of public health policy · 2022Review
- Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.Health economics · 2022Article
- Ethics of vaccination: Should capability measures be used to inform SARS-CoV-2 vaccination strategies?British journal of clinical pharmacology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms: ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.